Safety and effectiveness of direct oral anticoagulants for venous thromboembolism in patients with active cancer: a retrospective study

被引：0
|
作者：
Ogatal, M. [1 ]
Satake, H. [2 ]
Ama, Y. [1 ]
Hirabatake, M. [1 ]
Ogata, T. [1 ]
Yasui, H. [3 ]
Hashida, T. [1 ]
机构：
[1] Kobe City Med Ctr, Gen Hosp, Kobe, Hyogo, Japan
[2] Kansai Med Univ Hosp, Canc Treatment Ctr, Hirakata, Osaka, Japan
[3] Kobe City Med Ctr, Dept Med Oncol, Gen Hosp, Kobe, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 165
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [31] SAFETY OF DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF THROMBOEMBOLISM IN PEDIATRIC CANCER PATIENTS
    Scheuermann, Amanda
    Malec, Lynn
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S23 - S24
  • [32] Direct oral anticoagulants and venous thromboembolism
    Franchini, Massimo
    Mannucci, Pier Mannuccio
    EUROPEAN RESPIRATORY REVIEW, 2016, 25 (141): : 295 - 302
  • [33] Cost-effectiveness of direct oral anticoagulants for cancer-associated venous thromboembolism
    King, J.
    Bhat, S.
    Heath, L. J.
    Derington, C. G.
    Yu, Z.
    Clark, N. P.
    Witt, D. M.
    Reynolds, K.
    Lang, D. T.
    Xu, S.
    Bellows, B. K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3140 - 3140
  • [34] Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis
    Ross, Jeremy A.
    Miller, Marilyn M.
    Hernandez, Cristhiam M. Rojas
    THROMBOSIS RESEARCH, 2017, 150 : 86 - 89
  • [35] Comparative Effectiveness and Safety of Direct Oral Anticoagulants (DOAC) Versus Conventional Anticoagulation for the Treatment of Cancer-Related Venous Thromboembolism: A Retrospective Analysis
    Ross, Jeremy A.
    Miller, Marilyn
    Hernandez, Cristhiam M. Rojas
    BLOOD, 2015, 126 (23)
  • [36] Outcome of Elderly Patients with Venous Thromboembolism Treated with Direct Oral Anticoagulants-A Retrospective Cohort Study
    Ayalon-Dangur, Irit
    Vega, Yakov
    Israel, Miriam Rozi
    Grossman, Alon
    Spectre, Galia
    Shochat, Tzippy
    Leibovici, Leonard
    Gafter-Gvili, Anat
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [37] Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study
    Ahmed El-Bardissy
    Mohamed Nabil Elshafei
    Hebatullah Abdelgawad
    Rana Mekkawi
    Asma Eltahir
    AbdulMoqeeth Mohammed
    Ashour AM
    Hazem Elewa
    Thrombosis Journal, 23 (1)
  • [38] Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism
    Zeng, Jie
    Zhang, Xuhui
    Lip, Gregory Y. H.
    Shu, Xiaochen
    Thabane, Lehana
    Tian, Junzhang
    Li, Guowei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [39] Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer
    Cohen, Alexander
    Noxon, Virginia
    Dhamane, Amol
    Bruette, Robert
    Shah, Shrushti
    Hines, Dionne M.
    Alfred, Tamuno
    Luo, Xuemei
    THROMBOSIS RESEARCH, 2023, 226 : 117 - 126
  • [40] Recurrent venous thromboembolism in cancer patients treated with direct oral anticoagulants.
    Talbot, Alice
    Dean, Andrew Peter
    Brennan, Ciara
    Talbot, Thomas
    Angelov, Sophia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345